Fear versus fear: understanding vaccination rates

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

h/t to @edyong209 for the heads up on the study.

If it seems like plagues from bygone years are coming back, well, you’re right!  Due to growing objections within the United States to vaccination efforts, we are seeing a number of infectious diseases arising that even ten years ago we might have said were eradicated in the US.   The problem may seem larger than it is simply because we get so much more news so much more quickly and easily than we used to.  However, so far there have been 159 cases of measles, which is the highest yearly count since the mid-90s.  And there are still 3.5 months to go in 2013.  Texas has been in the news quite a bit recently for clusters of measles and whooping cough–both diseases with good vaccines that prevent infection when used correctly.

There are a number of reasons why parents choose not to vaccinate their children and one of these seems to be a lack of familiarity with these preventable diseases.  Once almost everyone got the measles and kids got really sick; some died.  Now, the idea of infectious diseases might seem quaint, distant and nonthreatening to parents with no frame of reference.  And of course, once a child gets a disease it’s too late.  A particularly scary report suggests even some younger doctors feel that infectious diseases aren’t such a big deal.

So you might think that this recent study, and others like it showing that the Human Papilloma Virus (HPV) vaccine is clearly reducing HPV infections throughout the body should be promoted even more strongly by public health officials.  Why?  Because HPV is known to cause cancer.  And if there’s anything that evokes the immediacy of fear in the area of health issues, it’s cancer.  That may not be the correct path however, and I’ll get to that in a minute, but first I just want to talk about the research.

The research study was a double-blinded clinical trial in which  7,466 women were inoculated at random with either an HPV vaccine or a control vaccine to hepatitis A.  At the end of the trial, the women were checked for evidence of oral HPV infections.  The vaccine had an estimated vaccine efficacy of about 93%, meaning it reduced infection rates about 14-15 fold.  This study is the first to demonstrate that HPV vaccinations can prevent oral HPV infections in addition to those at the cervix and other locations, as has been shown previously in other research.

That HPV infection is linked causally to the development of some cancers has been shown repeatedly.  Oral HPV infections contribute to the majority of oropharyngeal cancers. When these vaccines were developed, this was the basic argument:  that giving this vaccine to women would result in a decrease in HPV infections and subsequently a decrease in various cancers.  However, as has happened with many vaccines such as the Measles-Mumps-Rubella (MMR) shot, the scientific rationale became overshadowed by a number of other, unanticipated societal factors.

With the HPV vaccine, as Beth Skwarecki (@BethSkw) astutely pointed out on PLOS Blogs, maybe the key issue that wasn’t given enough attention in planning the vaccine rollout is that they way you get HPV is by having sex, and the age at which you should ideally give a person a vaccine is when they are 11 to 12 years old.  Or, to think about it another way, just when girls are starting to begin the maturation process into young women and parents have to face the reality that there is a good chance their child will be having sex sometime in the next 5-10 years.

And that’s scary.  Scarier than the possibility that your child might get cancer 20, 30 years down the road because he or she did not get vaccinated for HPV.  Beth also helpfully links to writing by David Ropeik about how fear can trump common sense with respect to things like, for example, vaccines.

It’s already known that people are lousy about understanding probability, and when you add an element of fear to this misunderstanding, one can see how vaccination campaigns even for something as straightforward as HPV face an uphill battle.

I mean, cancer!  If you can’t get people behind a preventative measure for cancer, what can you do?

And that is the question.  It’s not enough to just say that vaccinations should be mandated.  Sure government could do that, but the consequences could be quite large in terms of anger and pushback.  Would it have helped if in the beginning Merck had not pressed so strongly for every girl to be vaccinated?  Maybe, as some analyses after the fact suggest Merck involvement increased suspicion that all this was just some Pharma boondoggle.  That’s a post-hoc justification though, which I tend to distrust.

Ultimately it seems the answer will have to come from some combination of using subtler methods for incentivizing parents and better understanding of what people are afraid of.  Because right now it seems like even the fear of cancer isn’t enough.

Priming the pump: Biopharma contributions and prescribing patterns

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

How in control are we of the decisions we make every day?  How sure are we of our judgement, how we feel, what we believe?  I think many people would say they feel very in control and very certain.  I suspect many people are wrong.  Studies in behavioral psychology have begun identifying the effect of priming–how a subtle stimulus can affect how people, behave or think.  The field of priming is not without ongoing controversy, but at the same time the effect of priming has been seen in many studies (like this one) and appears to be a real phenomenon, albeit one that is still very challenging to clearly describe, test and validate.

Its in this context that a recent report describing physician prescribing patterns is particularly interesting.  And disturbing.  The study by Joseph Engelberg, Christopher Parsons and Nathan Tefft looked at the effect of Biopharma payments to what drugs doctors prescribe.  To quote from their introduction for some context:  “While such rent-seeking behavior [such as pushing more expensive merchandise by salespeople] might not surprise many people…that financial conflicts of interest could influence their doctor’s advice might be both less expected and more worrisome…intrinsic motivation is thought to be important in medicine, with the goal of optimizing patient health being a paramount objective.”  The null hypothesis would be that prescribing patterns would be related solely to health condition, general information about drug efficacy, and price to the patient.  That’s not what was found. Continue reading

Acid burn: how ocean acidity might make climate change worse

All opinions my own and do not necessarily reflect those of Novo Nordisk.

I was at the University District Farmer’s market this past weekend, thinking about making paella, and so I stopped by the shellfish booth and bought a pound of clams.  As I wandered around, looking for some tomatoes and onions, I swung my canvas bag, now heavy with thick-shelled Manila clams, and thought back to some time I spent in Spain during my first postdoc.  That’s when I learned to make paella.  That’s also where I studied calcification in the green alga Acetabularia acetabulum, which grows thick in the shallows of the waters of the Mediterranean.

Calcification is the process of depositing calcium carbonate along, within or around a biological structure.  It’s an important process in the oceans, contributing to ecological roles like protection via the shells of mollusks like the clams in my bag.  And it’s getting harder to do for ocean creatures to do because the oceans are becoming more acidic. Continue reading

Mulally and Microsoft

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

When news broke on Tuesday that some groups were lobbying for Alan Mulally to get a look as the next CEO of Microsoft, I was pretty positive.  Since then Jon Talton has written a more nuanced and cautionary view of this, suggesting, among other things, that celebrity CEOs are not always able to perform the miracles people are hoping for, and also that the history of CEOs switching fields and succeeding is sketchy.  These are good points, but I still find myself in the Mulally camp for two reasons.

One, in turning around Ford, Mulally demonstrated the ability to do what I think is one of the most important things a CEO can do.  He changed the culture.  To illustrate this let me relate a story that Mulally told at a lunch benefit for Leadership Tomorrow last year (disclosure: I’m on the board of Leadership Tomorrow, and Alan Mulally is one of the more well-known graduates of the program).  He related how when he came to Ford he was introduced to their weekly  status meeting, in which management representatives across the globe phoned in to a telecon for a status report.  And, in familiar corporate fashion, each representative was to indicate, via a green-yellow-red chart, how things were going with his or her domain.  At the first meeting, everything was green.  This from a company that was losing billions.  At that meeting Mulally stressed that what he wanted was the real story, and that no heads would roll because of it. Continue reading

Jeff Bezos is the anti-unbundler or, can the founder of Amazon make us eat our greens?

All opinions are may own and do not necessarily reflect those of Novo Nordisk.

h/t to @Frank_S_David for tweeting the link.

People have wondered and speculated and analyzed why exactly Jeff Bezos decided to buy the Washington Post.  Late last week Timothy B. Lee of the Washington Post offered some clues.  He reported how Bezos, in remarks to the Post staff, described wanting to get back to “that glorious bundle that the paper did so well.”  What Bezos wants is to find a way to make the Post such a destination that people will choose to visit regularly and not just read individual articles but stay and scan through many, presumably in one sitting, as people used to do as their morning ritual.

Timothy Lee is skeptical and I’ll just briefly summarize his points and urge you to go read his great article for the details.  Lee points out that news distribution has become unbundled due to the influence of the internet.  (For some nice posts on the concept of unbundling see this one by Leigh Drogan and this one by Frank David).  People consume news in individual article-sized chunks, often following links provided by friends and colleagues and search engines, without much loyalty to specific outlets or writers.  Lee also points out that while the Post has excellent writers, they’re still a miniscule fraction of the writers on the internet and most of the best writers are not on the Post’s staff.  Lee uses this as a launching point to talk about the increasingly important skillset of attracting clicks, largely through evocative headlines.  You know, like the one I tried to write for this post.  Did it work?

Jeff Bezos’ ambition is quite interesting on a couple of different levels.  The first is the basic question of why Bezos thinks he can do this?

The answer, I believe, is that he already succeeded once.

Continue reading